New blood thinner shows promise in heart stent patients
NCT ID NCT00508924
First seen Jan 07, 2026 · Last updated May 14, 2026 · Updated 22 times
Summary
This study tested three doses of a blood thinner called argatroban, given with standard anti-clotting drugs, in 140 people undergoing elective heart stent procedures. The goal was to see how well it prevents blood clots and bleeding compared to the usual blood thinner, heparin. Participants had stable coronary artery disease or unstable angina.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Study site
Aalst, Belgium
-
Study site
Bad Nauheim, Germany
-
Study site
Cologne, Germany
-
Study site
Dachau, Germany
-
Study site
Düren, Germany
-
Study site
Frankfurt, Germany
-
Study site
Halle, Germany
-
Study site
Mainz, Germany
Conditions
Explore the condition pages connected to this study.